About Xueming Qian

Dr. Qian has over 20 years of industrial antibody discovery and development experience. He was Senior VP and Head of R&D of Shenogen Pharma Group. And when he worked at Amgen as principal scientist, he led multiple project teams to discover novel antibody therapeutics for the autoimmune diseases and metabolic disorders (bone and kidney). He is the leading inventor of multiple antibody patents. Dr. Qian received his B.S. in Biophysics from Fudan University, M.A. in Neuroscience/Physiology from Columbia University and Ph.D. in Neuroscience and Pharmacology from Albany Medical Center.